{"id":"https://openalex.org/W4361884844","doi":"https://doi.org/10.1158/1078-0432.22460945","title":"Supplemental Information from IGF1R Protein Expression Is Not Associated with Differential Benefit to Concurrent Trastuzumab in Early-Stage HER2+ Breast Cancer from the North Central Cancer Treatment Group (Alliance) Adjuvant Trastuzumab Trial N9831","display_name":"Supplemental Information from IGF1R Protein Expression Is Not Associated with Differential Benefit to Concurrent Trastuzumab in Early-Stage HER2+ Breast Cancer from the North Central Cancer Treatment Group (Alliance) Adjuvant Trastuzumab Trial N9831","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361884844","doi":"https://doi.org/10.1158/1078-0432.22460945"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.22460945","doi":"https://doi.org/10.1158/1078-0432.22460945","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22460945","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1078-0432.22460945","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5090066966","display_name":"Monica Madden Reinholz","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Monica M. Reinholz","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074638556","display_name":"Beiyun Chen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Beiyun Chen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090009905","display_name":"Amylou Constance Dueck","orcid":"https://orcid.org/0000-0002-9912-1085","observed_orcids":["https://orcid.org/0000-0002-9912-1085"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Amylou C. Dueck","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085436504","display_name":"Kathleen Tenner","orcid":"https://orcid.org/0000-0003-4607-4286","observed_orcids":["https://orcid.org/0000-0003-4607-4286"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kathleen Tenner","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074015095","display_name":"Karla V. Ballman","orcid":"https://orcid.org/0000-0002-4492-0357","observed_orcids":["https://orcid.org/0000-0002-4492-0357"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Karla Ballman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035660420","display_name":"Darren Riehle","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Darren Riehle","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060720802","display_name":"Robert Brian Jenkins","orcid":"https://orcid.org/0000-0002-4049-694X","observed_orcids":["https://orcid.org/0000-0002-4049-694X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Robert B. Jenkins","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058661921","display_name":"Xochiquetzal J. Geiger","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xochiquetzal J. Geiger","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043134099","display_name":"Ann E. McCullough","orcid":"https://orcid.org/0000-0003-3778-4534","observed_orcids":["https://orcid.org/0000-0003-3778-4534"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ann E. McCullough","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5065306642","display_name":"Edith A. Perez","orcid":"https://orcid.org/0000-0002-5037-6677","observed_orcids":["https://orcid.org/0000-0002-5037-6677","https://orcid.org/0000-0001-7009-7467"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Edith A. Perez","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.001500000013038516,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10696","display_name":"Gastric Cancer Management and Outcomes","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/trastuzumab","display_name":"trastuzumab","score":0.9459999799728394},{"id":"https://openalex.org/keywords/her2-positive-breast-cancer","display_name":"HER2-positive breast cancer","score":0.9309999942779541},{"id":"https://openalex.org/keywords/early-breast-cancer","display_name":"early breast cancer","score":0.8970000147819519},{"id":"https://openalex.org/keywords/adjuvant-therapy","display_name":"adjuvant therapy","score":0.984000027179718},{"id":"https://openalex.org/keywords/disease-free-survival","display_name":"disease-free survival","score":0.9480000138282776},{"id":"https://openalex.org/keywords/tumor-heterogeneity","display_name":"tumor heterogeneity","score":0.5730000138282776},{"id":"https://openalex.org/keywords/lymph-node-status","display_name":"lymph node status","score":0.640999972820282}],"concepts":[{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.7505998611450195},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7005556225776672},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.6890161037445068},{"id":"https://openalex.org/C144174609","wikidata":"https://www.wikidata.org/wiki/Q14901457","display_name":"Insulin-like growth factor 1 receptor","level":4,"score":0.6448178887367249},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5540103316307068},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5136265158653259},{"id":"https://openalex.org/C23589133","wikidata":"https://www.wikidata.org/wiki/Q412005","display_name":"Hormone receptor","level":4,"score":0.4488008916378021},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.4434853196144104},{"id":"https://openalex.org/C2777982462","wikidata":"https://www.wikidata.org/wiki/Q2481887","display_name":"Adjuvant therapy","level":3,"score":0.42889273166656494},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4025719165802002},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.3328559398651123},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.3326403796672821},{"id":"https://openalex.org/C2775960820","wikidata":"https://www.wikidata.org/wiki/Q408378","display_name":"Growth factor","level":3,"score":0.12268581986427307}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1158/1078-0432.22460945","doi":"https://doi.org/10.1158/1078-0432.22460945","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22460945","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"doi:10.1158/1078-0432.22460945.v1","doi":"https://doi.org/10.1158/1078-0432.22460945.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22460945.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/22460945","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplemental_Information_from_IGF1R_Protein_Expression_Is_Not_Associated_with_Differential_Benefit_to_Concurrent_Trastuzumab_in_Early-Stage_HER2_sup_sup_Breast_Cancer_from_the_North_Central_Cancer_Treatment_Group_Alliance_Adjuvant_Trastuzum/22460945","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.22460945","doi":"https://doi.org/10.1158/1078-0432.22460945","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22460945","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2618728579","https://openalex.org/W4361951905","https://openalex.org/W2560355636","https://openalex.org/W2104558660","https://openalex.org/W2583013417","https://openalex.org/W1992581630","https://openalex.org/W2056727404","https://openalex.org/W2092294060","https://openalex.org/W2253219168","https://openalex.org/W4361944284"],"abstract_inverted_index":{"Supplemental":[0,12,22,38,64,88,99,105,121],"Table":[1,13,23,39,65],"1.":[2,90],"Heterogeneity":[3],"of":[4,17],"Cores":[5,10],"in":[6,96,114,130],"Patients":[7,43,48,69,115,131],"with":[8,44,70,116,132],"Multiple":[9],"(N=961)":[11],"2.":[14,101],"Clinicopathological":[15],"Characteristics":[16,26],"Cohort":[18],"and":[19],"Non-Cohort":[20],"Patients.":[21],"3.":[24,107],"Patient/Disease":[25],"by":[27,51,61,75,85,110,126],"{greater":[28],"than":[29],"or":[30],"equal":[31],"to}2+":[32],"IGF1R":[33,52,76,111,127],"protein":[34],"staining":[35],">0%":[36],"(N=1734).":[37],"4.":[40,123],"DFS":[41,67],"for":[42,68],"Hormone":[45,71,117,133],"Receptor":[46],"Positive":[47],"Breast":[49,73,119,135],"Tumors":[50,74],"Membrane":[53,77],"Staining":[54,78],"(0,1+":[55,79],"vs":[56,80],"2,3+":[57,81],")":[58,82],"N=909":[59],"(Stratified":[60,84],"nodal":[62,86],"status)":[63,87],"5.":[66],"Receptor-Negative":[72,134],"N=825":[83],"Figure":[89,100,106,122],"NCCTG":[91],"N9831":[92],"Trial":[93],"Incorporating":[94],"Trastuzumab":[95],"Adjuvant":[97],"Therapy":[98],"Patient":[102],"Flow":[103],"Diagram.":[104],"Disease-Free":[108,124],"Survival":[109,125],"Protein":[112,128],"Expression":[113,129],"Receptor-Positive":[118],"Tumors.":[120,136]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-04-05T00:00:00"}